FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Proposing Digital Health Center of Excellence

[ Price : $8.95]

FDA commissioner Scott Gottlieb and CDRH director Jeffrey Shuren propose a digital health Center of Excellence.

Liva Pharmaceuticals FDA-483

[ Price : $8.95]

FDA releases the FDA-483 with five observations from an inspection at Indias Live Pharmaceuticals.

Praluent sBLA Accepted for Reduced MACE Labeling

[ Price : $8.95]

FDA accepts for review a Sanofi and Regeneron Pharmaceuticals supplemental BLA for Praluent (alirocumab) to update the Prescribing...

Orphan Status for Syntimmune Pemphigus Therapy

[ Price : $8.95]

FDA grants Syntimmune an orphan drug designation for SYNT001 for treating pemphigus.

Merck sBLA for Keytruda in Lung Cancer

[ Price : $8.95]

FDA accepts for priority review a supplemental BLA for Keytruda, an anti-PD-1 therapy, as monotherapy for first-line treatment of ...

ANDA Clinical Study Dataset Guidance

[ Price : $8.95]

FDA publishes a guidance recommending technical specifications and general considerations for submitting certain ANDA comparative ...

CNS Drugs Longer to Develop, Approve: Tufts Center

[ Price : $8.95]

A Tufts Center for the Study of Drug Development analysis shows that central nervous system drugs take longer to develop and appro...

FDA Finds Violations in 2 Medtronic Inspections

[ Price : $8.95]

FDA warns two Medtronic manufacturing facilities about Quality System violations in their production of cardiac medical devices.

Integrate Cybersecurity in Medical Device Reviews: OIG

[ Price : $8.95]

The HHS Inspector General outlines steps FDA could take to better integrate cybersecurity concerns into its medical device reviews...

Panel to Review Pain Drug

[ Price : $8.95]

Federal Register notice: FDA announces a 10/11 Anesthetic and Analgesic Drug Products Advisory Committee meeting.